These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7535458)

  • 41. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral stem cell collection and transplantation in pediatric patients.
    Handgretinger R; Klingebiel T; Dopfer R; Siedner R; Baden B; Wendt S; Scheel-Walter HG; Scheel P; Schlander M; Niethammer D
    Prog Clin Biol Res; 1992; 377():615-20. PubMed ID: 1359568
    [No Abstract]   [Full Text] [Related]  

  • 43. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
    Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
    Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
    [No Abstract]   [Full Text] [Related]  

  • 44. Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.
    Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N
    Prog Clin Biol Res; 1994; 389():407-13. PubMed ID: 7535449
    [No Abstract]   [Full Text] [Related]  

  • 45. Source of stem cell rescue: bone marrow versus peripheral blood progenitors.
    Williams SF; Zimmerman T; Grad G; Mick R
    J Hematother; 1993; 2(4):521-3. PubMed ID: 7522110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
    Rosenfeld CS; Nemunaitis J
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
    [No Abstract]   [Full Text] [Related]  

  • 47. High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.
    van der Wall E; Nooijen WJ; Baars JW; Holtkamp MJ; Schorangel JH; Richel DJ; Rutgers EJ; Slaper-Cortenbach IC; van der Schoot CE; Rodenhuis S
    Br J Cancer; 1995 Apr; 71(4):857-62. PubMed ID: 7536025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous blood stem cell transplantation for patients with Hodgkin's disease in sensitive relapse.
    Haas R; Hohaus S; Ehrhardt R; Ogniben E; Boschmann G; Witt B; Hunstein W
    Prog Clin Biol Res; 1992; 377():621-7. PubMed ID: 1359569
    [No Abstract]   [Full Text] [Related]  

  • 49. Extramedullary hematopoiesis during therapy with granulocyte colony-stimulating factor.
    Redmond J; Kantor RS; Auerbach HE; Spiritos MD; Moore JT
    Arch Pathol Lab Med; 1994 Oct; 118(10):1014-5. PubMed ID: 7524465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematopoietic reconstitution with autologous stem cells.
    Juliusson G
    N Engl J Med; 1996 Jan; 334(4):271-2. PubMed ID: 8532015
    [No Abstract]   [Full Text] [Related]  

  • 51. Is CD33 a differentiation marker?
    Fritsch G; Buchinger P; Printz D; Dworzak MD; Strunk S; Agis H; Sliutz G; Wilfing A; Schulz U; Gadner H
    Prog Clin Biol Res; 1994; 389():377-82. PubMed ID: 7535445
    [No Abstract]   [Full Text] [Related]  

  • 52. Hematopoietic growth factors for the mobilization of peripheral blood stem cells.
    Haas R; Hohaus S; Goldschmidt H; Witt B; Hunstein W
    J Hematother; 1993; 2(3):357-9. PubMed ID: 7522890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE Spectra.
    Dzieczkowski JS; McGonigal M; Cook J; Sugrue M; Andersen J; Anderson KC
    Transfus Sci; 1995 Mar; 16(1):71-7. PubMed ID: 10155707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
    Deisseroth AB; Holmes F; Hortobagyi G; Champlin R
    Hum Gene Ther; 1996 Feb; 7(3):401-16. PubMed ID: 8835224
    [No Abstract]   [Full Text] [Related]  

  • 55. A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.
    Bachelot T; Gomez F; Biron P; Ray-Coquard I; Soler-Michel P; Philip I; Guastalla JP; Rebattu P; Dumortier A; Droz JP; Blay JY
    Br J Cancer; 2002 Nov; 87(10):1079-85. PubMed ID: 12402145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation.
    Stemmer SM; Maor Y; Hardan I
    Am J Clin Oncol; 2004 Aug; 27(4):328-32. PubMed ID: 15289723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interstitial pneumonitis as a late complication of high dose therapy with cyclophosphamide/thiotepa and peripheral blood progenitor cell rescue for carcinoma of the breast.
    Mahendra P; Hood IM; Lee MA; Mewar D; Bass G; Flower CD; Wilson CB; Marcus RE
    Clin Oncol (R Coll Radiol); 1996; 8(3):198-200. PubMed ID: 8814378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing of peripheral blood progenitor cell (PBPC) collections during recovery from chemotherapy supported by haematopoietic growth factor.
    Van Hoef ME; Baumann I; Lange C; De Wynter EA; Testa NG; Howell A
    Leukemia; 1994 Nov; 8(11):2020-1. PubMed ID: 7967747
    [No Abstract]   [Full Text] [Related]  

  • 59. High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
    Fields KK; Elfenbein GJ; Perkins JB; Moscinski LC
    Ann N Y Acad Sci; 1995 Dec; 770():288-304. PubMed ID: 8597367
    [No Abstract]   [Full Text] [Related]  

  • 60. Approaches to blood stem cell mobilisation. Initial Australian clinical results.
    Juttner CA; To LB; Haylock DN; Dyson PG; Bradstock KF; Dale BM; Enno A; Sage RE; Szer J; Toogood IR
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():22-4. PubMed ID: 1969302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.